China NT Pharma Group Company Limited (HKG:1011)

Market Cap	531.44M +115.9%
Revenue (ttm)	26.88M -36.4%
Net Income	-28.98M
EPS	-0.05
Shares Out	949.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	366,000
Open	0.5600
Previous Close	0.5600
Day's Range	0.5100 - 0.5600
52-Week Range	0.4000 - 1.3500
Beta	-2.00
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About HKG:1011

China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China. It operates through Digital Services and Sales Agency Service segments. The company acts as agent for clients to sell medical and health-related products to external customers. It also provides marketing and promotion in relation to bone health knowledge. In addition, the company is involved in trading of prescription medicines...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 21
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1011

Financial Performance

In 2025, HKG:1011's revenue was 24.16 million, a decrease of -36.36% compared to the previous year's 37.96 million. Losses were -26.04 million, -51.19% less than in 2024.

Financial numbers in CNY